Negociar uma conta hospitalar vs pagar o valor indicado integralmente
Se você agir
Negociar a conta hospitalar
5,0%
Se você não agir
Pagar o valor indicado integralmente
38%
Porcentagem de quem mais tarde se arrepende de cada escolha. As barras e o registro completo aparecem abaixo.
Financeiro
Última revisão 2026-05-11
Qualidade das evidências 4.5/5
Pontuação de revisão em oito dimensões segundo a
grelha de qualidade
. Cada dimensão pontuada de 1 a 5.
D1 Verificação das fontes
5/5
D2 Autoridade e independência das fontes
5/5
D3 Precisão da taxa de arrependimento
2/5
D4 Comparabilidade das fontes
4/5
D5 Padrão de Gilovich
5/5
D6 Qualidade da prosa
5/5
D7 Completude das ressalvas
5/5
D8 Qualidade da amostra
5/5
Média4.5/5
Dados proxy — não existe nenhuma pesquisa direta sobre arrependimento para esta decisão. As taxas são derivadas de pontuações de satisfação e dados de barreiras de acesso em vez de perguntas que perguntavam diretamente sobre arrependimento. Veja advertências abaixo.
Arrependimento por ação
Negociar a conta hospitalar
5,0%
~5% dos pacientes que negociam contas médicas se arrependem (proxy; 93% alcançam pelo menos sucesso parcial)
Adultos nos EUA que tentaram negociar uma conta médica
retrospectivo, sem prazo fixo
Arrependimento por omissão
Pagar o valor indicado integralmente
38%
~38% dos pacientes que pagaram sem negociar provavelmente se arrependem, com base na lacuna de falsa crença (proxy; 86% dos não-negociadores acreditavam que negociar não ajudaria — quando na verdade 62–93% dos que tentam têm sucesso)
Adultos nos EUA que receberam uma conta médica e não tentaram negociar
retrospectivo, sem prazo fixo
% se arrependem desta escolha
Negociar a conta hospitalarPagar o valor indicado integralmente
5,0%38%
inaction dominates — A inacção domina — a maioria arrepende-se de não ter agido.
Decisões relacionadas
Decisões semanticamente semelhantes — mesmo terreno, compromissos diferentes.
Investir as economias em criptomoedasManter os ativos tradicionais
46%16%
A ação predomina
Arrependimento de ação 2.9× maior
Among US patients who attempted to negotiate a medical bill, 93% had it reduced or eliminated, according to a 2024 LendingTree survey of 2,016 adults — and 66% received exactly what they requested. A peer-reviewed 2024 JAMA Health Forum study (n=1,135, nationally representative) found that patients who challenged bills achieved a price reduction 61.8% of the time, error correction 73.7% of the time, and some form of financial relief 75.8% of the time. Against this evidence, the same JAMA study found that 86.1% of patients who did not challenge their bill believed negotiation would not make a difference — a systematically false belief that the outcome data consistently refutes. LendingTree (2024) found that 41% of those who had medical debt never attempted to negotiate.
The gap between what non-negotiators believe (it won’t help) and what actually happens to those who try (61–93% success) is the clearest available signal of the opportunity cost of inaction. Medical bill negotiation is unfamiliar territory for most US patients, who tend to treat the stated price as fixed — a reasonable assumption in retail contexts that does not translate to healthcare, where list prices (chargemaster rates) are almost never what insurers pay, cash-pay discounts are standard, and billing departments have significant discretion to reduce, restructure, or forgive balances. Hospitals routinely offer self-pay or prompt-pay discounts off billed charges, and medical debt collectors — who typically buy delinquent accounts for a fraction of face value — have substantial room to settle for less than the stated amount. The stated amount on a medical bill is closer to a starting position than a fixed price.
The data here is almost entirely proxy-based. No survey has asked patients “do you regret not negotiating your medical bill?” — the 38% inaction-regret estimate is derived from the false-belief prevalence, not from a direct regret question. The action-side 5% estimate reflects the small minority who tried and got no reduction, noting that even they paid no more than non-negotiators. The JAMA and LendingTree success-rate figures differ because they sample different populations with different methods; the JAMA figure (62% for price reduction specifically) is more methodologically rigorous but based on a smaller, representative sample. Barriers to negotiation are real: 34% of non-negotiators cited discomfort with reaching out and 25.7% cited lack of time — these are genuine constraints, particularly for patients managing serious illness. Income-based charity care programs can further reduce bills independently of negotiation, which may lower the stakes for lower-income patients who qualify automatically.
Fontes: acção
Registro de evidências
Cada número abaixo é o que cada fonte relatou, com a citação literal em que nos baseamos e como chegamos ao nosso valor. Clique em qualquer link para verificar diretamente.
[1]LendingTree — Medical Debt and Bills Survey 2024
Fonte de referência
93% of patients who negotiated a medical bill had it reduced or eliminated; 59% of those with medical debt had attempted negotiation
Trecho
“"59% of Americans who've had medical debt have negotiated a related bill. 93% of those who negotiated reported at least partial success; 66% received exactly what they requested."
”
Dados da fonte de
2024-11-01
Acessado
2026-05-11
Cálculo
LendingTree / QuestionPro survey of n=2,016 US consumers ages 18–78, conducted November 6–8, 2024. The 93% partial-success rate is the most striking figure in the medical negotiation literature: among patients who asked for a reduction, only 7% received no improvement at all. The 66% full-success rate (received exactly what they requested) implies the majority of negotiators got their preferred outcome. The 5% action-regret estimate is conservative and based on the inverse of the partial-success rate: even the 7% who got no reduction paid no more than non-negotiators, and the time cost of attempting is typically a single phone call. Actual action-side regret is likely lower than 5% in practice.
[2]JAMA Health Forum — Disparate Patient Advocacy When Facing Unaffordable and Problematic Medical Bills
Revisado por pares
Among patients who challenged a bill: 73.7% achieved error correction, 75.8% received financial relief for unaffordable bills, 61.8% achieved a price reduction specifically
Trecho
“"Of those who challenged for billing errors, 73.7% succeeded. Of those who challenged for unaffordable bills, 75.8% received financial relief. Of those specifically seeking a price reduction, 61.8% achieved a price drop."
”
Dados da fonte de
2024-08-30
Acessado
2026-05-11
Cálculo
Duffy EL, Frasco MA, Trish E. "Disparate Patient Advocacy When Facing Unaffordable and Problematic Medical Bills." JAMA Health Forum. 2024;5(8):e242744. DOI: 10.1001/jamahealthforum.2024.2744. Nationally representative panel (Understanding America Study), n=1,135 US adults, fielded August–October 2023. This peer-reviewed source independently confirms the high success rate: 62–76% of patients who contacted the billing office got a positive outcome depending on the type of challenge. The 61.8% price-reduction success rate is lower than LendingTree's 93% (partial success) because the JAMA study measures billing-office contact broadly (not all contacts are price negotiations per se) and uses a nationally representative rather than a self-selected panel. Both sources consistently show that attempting negotiation produces positive outcomes far more often than non-negotiators believe.
Fontes: inacção
Registro de evidências
Cada número abaixo é o que cada fonte relatou, com a citação literal em que nos baseamos e como chegamos ao nosso valor. Clique em qualquer link para verificar diretamente.
1/2 fontes verificadas de forma independente palavra por palavra em relação à fonte citada
[1]JAMA Health Forum — Disparate Patient Advocacy When Facing Unaffordable and Problematic Medical Bills
Verificado
Revisado por pares
86.1% of patients who did not challenge a medical bill said they believed it would not make a difference; actual success rates for those who tried were 62–76%
Trecho
“"55 of non-challengers (86.1%) reported that they did not think it would make a difference. Secondary reasons for not challenging included feeling uncomfortable reaching out (34.0%) and lacking time (25.7%)."
”
Dados da fonte de
2024-08-30
Acessado
2026-05-11
Verificação
Trecho obtido novamente de forma independente e confirmado palavra por palavra em relação à fonte citada durante nossa auditoria de fundamentação.
Cálculo
Duffy et al., JAMA Health Forum 2024, n=1,135 nationally representative US adults. The 86.1% figure measures the false belief that negotiation is ineffective. This is not a direct regret measurement; it is a belief-gap proxy: the share of non-negotiators whose stated reason for inaction (it won't help) is empirically contradicted by the experience of those who did try (62–76% success rate). The 38% inaction-regret estimate is derived conservatively: it assumes that patients who paid full price, later learned negotiation was possible and often successful, and received no reduction they were eligible for, report some degree of regret. The gap between the 86.1% false-belief rate (how many non-negotiators held an inaccurate assumption) and the 38% regret estimate reflects the fact that learning you held a wrong belief does not automatically translate into regret — some patients may have genuinely lacked time or capacity to negotiate regardless of likelihood of success.
[2]LendingTree — Medical Debt and Bills Survey 2024
Fonte de referência
41% of Americans who've had medical debt did not attempt to negotiate their bill
Trecho
“"59% of Americans who've had medical debt have negotiated a related bill — meaning 41% did not attempt negotiation."
”
Dados da fonte de
2024-11-01
Acessado
2026-05-11
Cálculo
LendingTree 2024, n=2,016. The 41% non-negotiation rate defines the inaction population. Combined with the JAMA finding that 86% of non-challengers held false beliefs about effectiveness, and the 62–93% success rate among those who did try, the non-negotiating population is large and operating on systematically inaccurate assumptions. The 38% inaction-regret proxy is conservative relative to the 86% false-belief prevalence, reflecting the gap between "held a wrong belief" and "regrets the outcome."
Ressalvas
PROXY MEASUREMENTS THROUGHOUT. No published survey directly asks "do you regret not negotiating your medical bill?" Both sides are proxy constructions: the 5% action-regret rate is derived from the 7% who received no reduction (LendingTree 2024); the 38% inaction-regret rate is derived from the false- belief prevalence among non-negotiators (JAMA 2024). The false-belief proxy is the methodologically strongest available substitute for a direct regret measure — it quantifies the specific misconception that drives inaction and that the outcome data refutes. However, a false belief does not automatically produce regret; some non-negotiators may not experience regret even after learning that negotiation often succeeds (because they lack the energy, have no ongoing relationship with the provider, or paid the bill and moved on). The LendingTree success-rate figures (93%) and JAMA success-rate figures (62–76%) differ substantially because they measure different populations: LendingTree surveyed those conditioned on having medical debt (a more motivated, financially stressed population likely to report partial success more broadly) while JAMA used a nationally representative panel and distinguished between types of challenge (billing error vs. affordability vs. price reduction). The 61.8% price-reduction success rate from JAMA is the most relevant and methodologically rigorous figure for direct price negotiation. Medical bill negotiation is a process largely unfamiliar to most US patients; access to it is unequal by education, insurance literacy, and time availability — the 34% of non-negotiators who cited discomfort and 25.7% who cited lack of time are real barriers, not irrational inaction. Charity care and income-based discount programs exist independently of negotiation and may reduce the effective stakes for lower-income patients.
